# Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients

> **NCT04950673** · — · UNKNOWN · sponsor: **Cognivue, Inc.** · enrollment: 1000 (estimated)

## Conditions studied

- Cognitive Decline
- Cognitive Dysfunction
- Brain Health
- Post CoV-2 Syndrome
- COVID Long-Haul

## Interventions

- **DEVICE:** Cognivue

## Key facts

- **NCT ID:** NCT04950673
- **Lead sponsor:** Cognivue, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-21
- **Primary completion:** 2023-11-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2022-06-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04950673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04950673, "Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04950673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*